Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4678-4688

  Ahmad, Faiyaz ^a,b   Cong, Li Na ^a   Holst, Lena Stenson ^c   Wang, Ling Mei ^d   Landstrom, Tova Rahn ^c   Pierce, Jaclyn H ^d   Quon, Michael J ^a   Degerman, Eva ^c   Manganiello, Vincent C ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c LUND UNIVERSITY   (Sweden)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; PROTEIN KINASE B; SOMATOMEDIN C; THYMIDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 0034192086     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4678     Document Type: Article

References (85)

1. Alessi, D. R. and P. Cohen. 1998. Mechanism and activation of protein kinase B. Curr. Opin. Genet. Dev. 8:55.
2. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKT ion blocks apoptosis. Cell 88:435.
3. Hemmings, B. A. 1997. Akt signaling: linking membrane events to life and death decisions. Science 275:628.
4. Cong. L.-N., H. Chen, Y. Li, L. Zhou, M. A. McGibbon, S. I. Taylor, and M. J. Quon. 1997. Physiological role of Akt in insulin-stimulated translocation of GLUT-4 in transfected rat adipose cells. Mat. Endocrinol. 11:1881.
5. Kohn, A., S. A. Simmons, M. J. Birnbaum, and R. A. Roth. 1996. Expression of constitutively active Akt Ser/Thr kinase in 3T3-LI adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271:31372.
6. Cross, D., P. Watt, M. Shaw, J. van der Kay, C. Downes, J. Holiday, and P. Cohen. 1997. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett. 406:211.
7. Ueki, K., R. Yamamoto-Horda, Y. Kaburagi, T. Yamauchi, K. Tobe, B. Bugering, P. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis and protein synthesis. J. Biol. Chem. 273:5315.
8. Andersen, C., R. Roth, and M. Conti. 1998. Protein kinase B/Akt induces resumption of meiosis in Xenopus oocytes. J. Biol. Chem. 273:18705.
9. Kulek, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signaling by the insulin-like growth factor receptor 1, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 17:1595.
10. Del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687.
11. Songyang, Z., D. Baltimore, L. Cantley, D. Kaplan, and T. Franke. 1997. Interleukin-3 dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 91:11345.
12. Cross, D., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785.
13. Deprez, J., D. Vertommen, D. Alessi, L. Hue, and M. Rider. 1997. Phosphorylation and activation of heart 6-phosphofructokinase by protein kinase B and other kinases of the insulin signaling cascades. J. Biol. Chem. 272:17269.
14. Brunei, A., A. Bonni, M. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857.
15. Fulton, D., J.-P. Gratton, T. J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T. F. Franke, A. Papapetropoulos, and W. C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597.
16. Degerman, E., P. Belfrage, and V. C. Manganiello. 1997. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272: 6823.
17. Wijkander, J., T. Rahn Landstrom, V. C. Manganiello, P. Belfrage, and E. Degerman. 1998. Insulin induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70S6 kinase. Endocrinology 139:219.
18. Kitamura, T., Y. Kitamura, S. Kuroda, Y. Hino, M. Ando, K. Kotani, H. Konishi, H. Matsuzaki, U. Kikkawa, W. Ogawa, and M. Kasuga. 1999. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by serine-threonine kinase Akt. Mol. Cell. Biol. 19:6286.
19. Belfrage, P., J. Donner, H. Eriksson, and P. Stralfors. 1986. Mechanisms for control of lipolysis by insulin and growth hormone. In Mechanisms of Insulin Action. P. Belfrage, J. Donner, and P. Stralfors, eds. Elsevier, Amsterdam, pp. 323-340.
20. Eriksson, H., M. Ridderstrale, E. Degerman, D. Ekholm, C. Smith, V. C. Manganiello, and P. Belfrage. 1995. Evidence for the role of the cGMP-inhibited phosphodiesterase in the antilipolytic action of insulin. Biochim. Biophys. Acta 1266:101.
21. Rahn, T., M. Ridderstrale, H. Tornqvist, V. C. Manganiello, G. Fredrickson, P. Belfrage, and E. Degerman. 1994. Essential role of phosphatidylinositol-3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes using the selective inhibitor wortmannin. FEBS Lett. 350:314.
22. Wang, L. M., M. G. Myers, X. J. Sun, S. A. Aaronson, M. White, and J. H. Pierce. 1993. IRS-1 is essential for insulin stimulated and IL-4 stimulated mitogenesis in hematopoietic cells. Science 261:1591.
23. Sun, X.-J., S. Pons, L.-M. Wang, Y. Zhang, L. Yenush, D. Burks, M. Myers, Jr., E. Glastein, N. Copeland, N. Jenkins, J. Pierce, and M. White. 1997. The IRS-2 gene on murine chromosome 8 encodes a unique signalling adapter for insulin and cytokine action. Mol. Endocrinol. 11:251.
24. Wang, L. M., A. D. Keegan, W. Q. Li, G. E. Lienhard, J. S. Gutkind, M. G. Myer, X. J. Sun, M. F. White, S. A. Aaronson, W. E. Paul, and J. H. Pierce. 1993. Common elements in interleukin-4 and insulin signaling pathways in factor dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032.
25. Wang, L.-M., A. D. Keegan, W. E. Paul, M. A. Heideran, J. S. Gutkind, and J. H. Pierce. 1992. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J. 11:4899.
26. Ahmad, F., G. Gao, L.-M. Wang, T. Rahn-Landstrom, E. Degerman, J. Pierce, and V. C. Manganiello. 1999. Interleukin-3 and interleukin-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) hy different mechanisms in FDCP2 cells. J. Immunol. 162:4864.
27. Quon, M. J., M. J. Zamowski, M. Guerremillo, M. D. Siena, S. I. Taylor, and S. W. Cushman. 1993. Transfection of DNA into isolated rat adipose cells by electroporation: evaluation of promoter activity in transfected adipose cells which are highly responsive to insulin after one day in culture. Biochem. Biophys. Res. Commun. 194:338.
28. Datta, K., A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1996. Akt is a direct target of the phosphatidylinositol 3-kinase: activation by growth factors. v-src and v-Ha-ras, in Sf9 and mammalian cells. J. Biol. Chem. 271:30835.
29. Klippel, A., C. Reinhard, M. W. Kavanaugh, G. Apell, M. A. Escobedo, and L. T. Williams. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol. 16:4117.
30. Pierce, J., M. Ruggiero, T. Fleming, P. DiFiore, J. Greenberger, L. Varticovski, J. Schlessinger, G. Rovera, and S. Aaronson. 1988. Signal transduction through the EGF receptor transfected in IL-3 dependent hematopoietic cells. Science 239: 628.
31. Ekholm, D., B. Hemmer, G. Gao, M. Vergelli, R. Martin, and V. C. Manganiello. 1997. Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein. J. Immunol. 159:1520.
32. Beavo, J., and D. Reifsnyder. 1990. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Biochem. Sci. 11:150.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680.
34. Leroy, M.-J., E. Degerman, M. Taira, T. Murata, L.-H. Wang, M. Movsesian, E. Meacci, and V. C. Manganiello. 1996. Characterization of two recombinant PDE3 (cGMP-inhihited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells. Biochemistry 35:10194.
35. Moule, S. K., G. Welsh, N. Edgell, E. Foulstone, C. Proud, and R. Denton. 1997. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and β-adrenergic agents in rat epididymal fat cells. J. Biol. Chem. 272:7713.
36. Wijkander, J., L. S. Holst, T. Rahn, S. Resjo, I. Castan, V. C. Manganiello, P. Belfrage, and E. Degerman. 1997. Regulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate: membrane translocation in response to peroxovanadate. J. Biol. Chem. 272:21520.
37. Andjelkovic, M., D. Alessi, R. Meier, A. Fernandez, N. Lamb, M. Frech, P. Cron, P. Cohen, J. Lucocq, and B. A. Hemmings. 1997. Role of translocation in activation and function of protein kinase B. J. Biol. Chem. 272:31515.
38. Kohn, A. D., A. Barthel, K. S. Kovacina, A. Boge, B. Wallach, S. A. Summers, M. J. Birnbaum, P. H. Scott, J. C. Lawrence, and R. A. Roth 1998. Construction and characterization of a constitutively active version of the serine/threonine kinase Akt. J. Biol. Chem. 273:11937.
39. Mackenzie, S. J., S. Yarwood, A. Peden, G. Bolger, R. Vernon, and M. Houslay. 1998. Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidyl-inositol 3-kinase pathway leads to activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-442A preadipocytes. Proc. Natl. Acad. Sci. USA 95:3549.
40. Ahmad, N., H. L. Grimes, A. Bellacosa, T. Chan, and P. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals by Akt protein kinase. Proc. Natl. Acad Sci. USA 94:3627.
41. 2-mediated apoptosis in B-cell lymphomas. J. Immunol. 157:1359.
42. Lalli, E., P. Sassone-Corsi, and R. Ceredig. 1996. Block of T-lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J. 15:528.
43. McConkey, D., S. Orrenius, and M. Jondal. 1990. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 145:1227.
44. Shalhegg, B., B. Landmark, S. Doskeland, V. Hansson, T. Lea, and T. Johnson. 1992. Cyclic AMP-dependent protein kinase type 1 mediates the inhibitory effects of cAMP on cell replication in T-lymphocytes. J. Biol. Chem. 267:15707.
45. Aharoni, D., A. Dantes, M. Oren, and A. Amsterdam. 1995. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell Res. 218:271.
46. Friedman, D. L., R. Johnson, and C. Zeilig. 1976. The role of cyclic nucleotides in the cell cycle. Adv. Cyclic Nucleotide Res. 7:69.
47. Pastan, I. H., G. S. Johnson, and W. B. Anderson. 1974. Role of cyclic nucleotides in growth control. Adv. Cancer Res. 19:303.
48. Roger, P. P., S. Reuse, C. Maenhaut, and J. E. Dumont. 1995. Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51:59.
49. Tomlinson, P., J. Wilson, and A. Stewart. 1995. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture, relationship to elevated cAMP levels. Biochem. Pharmacol. 49:1809.
50. + T-lymphocytes: role in regulating proliferation and the synthesis of interleukin-2. Br. J. Pharmacol. 118:1945.
51. Jiang, X., J. Li, M. Paskind, and D. Epstein. 1996. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc. Natl. Acad. Sci. USA 93:11236.
52. Kim, D.-H., and A. Lerner. 1998. Type 4 adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia. Blood 92:2484.
53. Robicsek, S., D. Blanchard, J. Djeu, J. Krzanowski, A. Szentwvanyi, and J. Polson. 1991. Multiple high-affinity cAMP phosphodiesterases in human T-lymphocytes. Biochem. Pharmacol. 42:869.
54. Souness, J., G. Hassal, and D. Parrot. 1992. Inhibition of pig aortic smooth muscle DNA synthesis by selective type III and type IV cAMP phosphodiesterase inhibitors. Biochem. Pharmacol. 48:827.
55. Drees, M., R. Zimmerman, and G. Eisenbard. 1993. 3′5′-Cyclic nucleotide phosphodiesterases in tumor cells as potential targets for tumor growth inhibition. Cancer Res. 53:3058.
56. Chen, D., and E. Rothenberg. 1994. Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition-kinetics and combinatorial transcription roles. J. Exp. Med. 179:931.
57. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069.
58. Ivashkev, L., E. Schmitt, and A. Castro. 1996. Inhibition of transcription factor Stat 1 activity in mononuclear cell cultures and T-cells by the cyclic AMP signaling pathway. J. Immunol. 157:1415.
59. 1 phase arrest mediated by an inhibitor of cyclin-dependent kinase 4. Cell 79:487.
60. Rao, G., and M. Runge. 1996. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J. Biol. Chem. 271:20805.
61. Tamir, A., Y. Granot, and N. Isakov. 1996. Inhibition of T-lymphocyte activation is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J. Immunol. 157:1514.
62. Downs, S. M., and M. Hunzicker-Dunn. 1995. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus complex by site-selective analogs of cyclic adenosine monophosphate. Dev. Biol. 172:72.
63. Monfar, M., K. Lemon, T. Grammar, L. Cheatham, L. Chung, C. Vlakos, and J. Blenis. 1995. Activation of pp70/85 S6 kinase in IL-2-responsive cells is mediated by phosphatidylinositol 3-kinase and inhibited by cAMP. Mol. Cell. Biol. 15:326.
64. Pirson, I., K. Coulonval, F. Lamy, and J. E. Dumont. 1996. C-Myc expression is controlled by the mitogenic cAMP-cascade in thymocytes. J. Cell. Physiol. 168: 59.
65. Parvathenani, L. K., E. S. Buescher, E. Chacon-Cruz, and S. Beebe. 1998. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J. Biol. Chem. 273:6736.
66. Franke, T., and L. Cantley. 1997. A BAD kinase makes good. Nature 390:116.
67. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231.
68. Harada, H., B. Becknell, M. Wilm, M. Mann, L. Huang, S. S. Taylor, J. D. Scott, and S. J. Korsmeyer. 1999. Phosphorylation and inactivation of BAD by the mitochondria-anchored protein kinase A. Mol. Cell 3:413.
69. Parrizas, M., A. Saltiel, and D. LeRoith. 1997. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidyl 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154.
70. Scheid, M. D., and V. Duorino. 1998. Dissociation of cytokine-induced phosphorylation of BAD and activation of PKB/Akt: involvement of MEK upstream of BAD phosphorylation. Proc. Natl. Acad. Sci. USA 95:7439.
71. Klee, C. B., H. Ren, and X. Wang. 1998. Regulation of the calmodulin-stimulated phosphatase, calcineurin. J. Biol. Chem. 273:13367.
72. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339.
73. Minishall, C., S. Arkins, R. Danker, G. C. Freund, and K. W. Kelley. 1999. Phosphatidyl-3-kinase, but not S6-kinase, is required for insulin-like growth factor-1 and 1L-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. J. Immunol. 162:4542.
74. Cheng, J., A. Goodwin, A. Bellacosa, T. Taguchi, T. Franke, T. Hamilton, P. Tsichles, and J. Testa. 1992. AKT2, a putative protooncogene encoding a subfamily of protein serine kinases is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 89:9267.
75. Cheng, J., B. Ruggeri, W. Klein, G. Sonoda, D. Altomare, D. Watson, and J. Testa. 1996. Amplification of AKT2 in human pancreatic-cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA 93:3636.
76. Rahn, T., L. Ronnstrand, M.-J. Leroy, C. Wernstedt, H. Tornqvist, V. C. Manganiello, P. Belfrage, and E. Degerman. 1996. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J. Biol. Chem. 211:11575.
77. Zhao, A., H. Zhao, J. Teague, W. Fujimoto, and J. Beavo. 1997. Attenuation of insulin secretion by IGF-1 is mediated through activation of phosphodiesterase 3B. Proc. Natl. Acad. Sci. USA 94:3223.
78. Pyne, N., M. Cooper, and M. Houslay. 1987. The insulin-and glucagon-stimulated "dense vesicle" high affinity cAMP phosphodiesterase from rat liver. Biochem. J. 242:33.
79. 21 ras in Xenopus laevis oocytes. Mol. Endocrinol. 5:1939.
80. Sadler, S., and J. Mailer. 1987. In vivo regulation of cAMP phosphodiesterase in Xenopus oocytes: stimulation by insulin and IGF-1. J. Biol. Chem. 262:10644.
81. Londos, C., R. Honor, and C. S. Dhillon. 1985. cAMP-dependent protein kinase and lipolysis in rat adipocytes III. J. Biol. Chem. 260:15781.
82. Beebe, S. J., J. Redmon, P. Blackmore, and J. Corbin. 1985. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatic glycogenolysis. J. Biol. Chem. 260:15781.
83. Conti, M., G. Nemoz, C. Sette, and E. Vicini. 1995. Recent progress in understanding regulation of phosphodiesterases. Endocr. Rev. 16:370.
84. Houslay, M., and G. Milligan. 1997. Tailoring cAMP responses through isoform multiplicity. Trends Biochem. Sci. 22:217.
85. Torphy, T. 1998. Phosphodiesterase isoenzymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 157:351.